Recruiting

Stem Cells

Sponsor:

Herbert Irving Comprehensive Cancer Center

Code:

NCT00899119

Conditions

Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

leukapheresis

Study Details

Brief summary:

RATIONALE: Collecting and storing stem cells to study in the laboratory may help doctors learn more about collecting stem cells from patients who have undergone treatment for Waldenstrom's macroglobulinemia.

PURPOSE: This laboratory study is collecting stem cells from patients with Waldenstrom's macroglobulinemia.

Conditions

Lymphoma

Study ID

NCT00899119

Start date

Nov, 2005

Status verified date

Jan, 2008

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

DISEASE CHARACTERISTICS:

  • Diagnosis of Waldenstrom's macroglobulinemia (WM)
  • Less than 30% lymphoplasmacytoid cells in bone marrow by histopathology
  • Received prior chemotherapy for WM

PATIENT CHARACTERISTICS:

  • ECOG performance status 0-1
  • WBC > 2,000/mm³
  • Platelet count > 50,000/mm³
  • LVEF ≥ 50%
  • No organ dysfunction that would preclude future transplantation

PRIOR CONCURRENT THERAPY:

  • See Disease Characteristics

Study Design

Enrollment

40 participants

Anticipated

Interventions and Outcome Measures

Interventions

leukapheresis

Primary outcome measure

  • Number of days to adequate stem cell harvest [ Time Frame: undefined ]

Central Contacts and Locations

Locations

Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center

Recruiting

New York, New York, United States, 10032

Contacts

Clinical Trials Office - Herbert Irving Comprehensive Cancer C

212-305-8615

More Information

Sponsor

Herbert Irving Comprehensive Cancer Center

Last update posted

Dec 18, 2013

Last verified

Jan, 2008

Keywords

  • Waldenström macroglobulinemia

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Herbert Irving Comprehensive Cancer Center on 2013-12-18.